Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Kidney Function Test Market by Product (Dipsticks, Reagents, Disposables), by Type (Urine Tests, Blood Tests) and by End Users (Hospitals, Diagnostics Laboratories, Research Laboratories and Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A07630

Pages: NA

Charts: NA

Tables: NA

Kidney function test market is expected to grow in upcoming years due to factors such as increase in prevalence of kidney related disorders, rise in diabetes and hypertension patients, rapid growth of geriatric population across the world and high consumption of alcohol.

Kidneys are considered as an important organ in the human body. Kidney filters blood and reabsorbs the essential elements and removes the soluble waste products from the blood. They require continuous regeneration of dead nephrons and right circulation of blood to maintain growth of cells. The kidney function tests determine the disorder related to the kidney or renal function and helps doctors to prescribe specific medication. Kidney function test are segmented into dilution test, clearance test, and others. Kidney disorders such as difficulty in urination due to increased body fluids, swelling in hands or feet, swollen face can be diagnosed with the use of kidney function test.

 

 COVID-19 scenario analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on the kidney function test market.

Top Impacting factors:

  • Factors such as increase in prevalence of kidney disorders due to rise in alcohol consumption, are driving the growth for the kidney function test market.
  • Technological advancements made in the renal function test process has resulted in the early diagnosis of the diseases.
  • Change in sedentary lifestyle, rise in obesity and increase in prevalence of diabetes and cardiovascular diseases have led to the growth of the kidney function test market.
  • Rapidly growing geriatric population and increase in awareness by private and public healthcare organizations for early diagnosis has resulted in the market growth.
  • However, factors such as stringent government regulation in procedures for kidney function test and inability of the test to completely determine the disease is expected to hamper the growth of market during the forecast period.

New Product Launch / News:

  • In June 2020, Kidney disease diagnostics firm RenalytixAI announced that it has received a clinical laboratory permit from the New York State Department of Health allowing the company to provide its KidneyIntelX test to residents of the state.
  • In March 2020, Horizon Therapeutics plc announced the launch of “Down and Out Kidney”, a campaign to highlight the damaging effects associated with the accumulation of uric acid and gout in people with chronic kidney disease (CKD).
  • In May 2019, CareDx announced the launch of a new model built for kidney transplants which has incorporated Predictive Al for patients suffering from chronic kidney diseases.What Segments and region will drive the Kidney Function Test Market growth & why?

 Key Market Segments

  • By Product
    • Dipsticks
    • Reagents
    • Disposables
  • By Type
    • Urine Tests
      • Urine Protein Tests
      • Microalbumin Tests
      • Creatinine Clearance Tests
    • Blood Tests
      • Serum Creatinine Tests
      • Blood Urea Nitrogen Tests
      • Glomerular Filtration Rate Tests
  • By End Users
    • Hospitals
    • Diagnostics Laboratories
    • Research Laboratories and Institutes
  • By Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • rest of LAMEA

 
Key Market Players

  • Beckman Coulter
  • 77 Elektronika
  • Siemens
  • Randox Laboratories
  • Sysmex
  • Merck KGaA
  • ARKRAY
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • bioMérieux SA
  • OPTI Medical
  • URIT Medical
  • Abbott
  • Nova Biomedical
  • Roche

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: KIDNEY FUNCTION TEST MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Dipsticks

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Reagents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Disposables

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: KIDNEY FUNCTION TEST MARKET, BY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Type

    • 5.2. Urine Tests

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Urine Protein Tests

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Microalbumin Tests

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Creatinine Clearance Tests

        • 5.2.4.1. Market Size and Forecast

    • 5.3. Blood Tests

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

      • 5.3.4. Serum Creatinine Tests

        • 5.3.4.1. Market Size and Forecast

      • 5.3.4. Blood Urea Nitrogen Tests

        • 5.3.4.1. Market Size and Forecast

      • 5.3.4. Glomerular Filtration Rate Tests

        • 5.3.4.1. Market Size and Forecast

  • CHAPTER 6: KIDNEY FUNCTION TEST MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Diagnostics Laboratories

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Research Laboratories And Institutes

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: KIDNEY FUNCTION TEST MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Type

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Kidney Function Test Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Type
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Kidney Function Test Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Type
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Kidney Function Test Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Type
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Type

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Kidney Function Test Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Type
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Kidney Function Test Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Type
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Kidney Function Test Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Type
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Kidney Function Test Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Type
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Kidney Function Test Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Type
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Kidney Function Test Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Type
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Kidney Function Test Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Type
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Type

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Kidney Function Test Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Type
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Kidney Function Test Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Type
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Kidney Function Test Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Type
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Kidney Function Test Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Type
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Kidney Function Test Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Type
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Kidney Function Test Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Type
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Kidney Function Test Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Type
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Kidney Function Test Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Type
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Kidney Function Test Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Type
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Type

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Kidney Function Test Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Type
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Kidney Function Test Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Type
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Kidney Function Test Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Type
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Kidney Function Test Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Type
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Kidney Function Test Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Type
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Kidney Function Test Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Type
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Beckman Coulter

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Siemens

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Nova Biomedical

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Roche

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Abbott

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. URIT Medical

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. ARKRAY

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. OPTI Medical

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Sysmex

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. 77 Elektronika

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Randox Laboratories

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. BioMérieux SA

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. Quest Diagnostics Incorporated

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

    • 9.14. Merck KGaA

      • 9.14.1. Company Overview

      • 9.14.2. Key Executives

      • 9.14.3. Company Snapshot

      • 9.14.4. Operating Business Segments

      • 9.14.5. Product Portfolio

      • 9.14.6. Business Performance

      • 9.14.7. Key Strategic Moves and Developments

    • 9.15. Laboratory Corporation Of America Holdings

      • 9.15.1. Company Overview

      • 9.15.2. Key Executives

      • 9.15.3. Company Snapshot

      • 9.15.4. Operating Business Segments

      • 9.15.5. Product Portfolio

      • 9.15.6. Business Performance

      • 9.15.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL KIDNEY FUNCTION TEST MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL KIDNEY FUNCTION TEST MARKET FOR DIPSTICKS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL KIDNEY FUNCTION TEST MARKET FOR REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL KIDNEY FUNCTION TEST MARKET FOR DISPOSABLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL KIDNEY FUNCTION TEST MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL KIDNEY FUNCTION TEST MARKET FOR URINE TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL KIDNEY FUNCTION TEST MARKET FOR BLOOD TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL KIDNEY FUNCTION TEST MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL KIDNEY FUNCTION TEST MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL KIDNEY FUNCTION TEST MARKET FOR DIAGNOSTICS LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL KIDNEY FUNCTION TEST MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL KIDNEY FUNCTION TEST MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA KIDNEY FUNCTION TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 17. U.S. KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. U.S. KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 20. CANADA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. CANADA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE KIDNEY FUNCTION TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. ITALY KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. ITALY KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ITALY KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. UK KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. UK KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. UK KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC KIDNEY FUNCTION TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 55. CHINA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. CHINA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. CHINA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. INDIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. INDIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. INDIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA KIDNEY FUNCTION TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 95. UAE KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 96. UAE KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 97. UAE KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA KIDNEY FUNCTION TEST, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA KIDNEY FUNCTION TEST, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA KIDNEY FUNCTION TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 104. BECKMAN COULTER: KEY EXECUTIVES
  • TABLE 105. BECKMAN COULTER: COMPANY SNAPSHOT
  • TABLE 106. BECKMAN COULTER: OPERATING SEGMENTS
  • TABLE 107. BECKMAN COULTER: PRODUCT PORTFOLIO
  • TABLE 108. BECKMAN COULTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. SIEMENS: KEY EXECUTIVES
  • TABLE 110. SIEMENS: COMPANY SNAPSHOT
  • TABLE 111. SIEMENS: OPERATING SEGMENTS
  • TABLE 112. SIEMENS: PRODUCT PORTFOLIO
  • TABLE 113. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. NOVA BIOMEDICAL: KEY EXECUTIVES
  • TABLE 115. NOVA BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 116. NOVA BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 117. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 118. NOVA BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. ROCHE: KEY EXECUTIVES
  • TABLE 120. ROCHE: COMPANY SNAPSHOT
  • TABLE 121. ROCHE: OPERATING SEGMENTS
  • TABLE 122. ROCHE: PRODUCT PORTFOLIO
  • TABLE 123. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. ABBOTT: KEY EXECUTIVES
  • TABLE 125. ABBOTT: COMPANY SNAPSHOT
  • TABLE 126. ABBOTT: OPERATING SEGMENTS
  • TABLE 127. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 128. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. URIT MEDICAL: KEY EXECUTIVES
  • TABLE 130. URIT MEDICAL: COMPANY SNAPSHOT
  • TABLE 131. URIT MEDICAL: OPERATING SEGMENTS
  • TABLE 132. URIT MEDICAL: PRODUCT PORTFOLIO
  • TABLE 133. URIT MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. ARKRAY: KEY EXECUTIVES
  • TABLE 135. ARKRAY: COMPANY SNAPSHOT
  • TABLE 136. ARKRAY: OPERATING SEGMENTS
  • TABLE 137. ARKRAY: PRODUCT PORTFOLIO
  • TABLE 138. ARKRAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. OPTI MEDICAL: KEY EXECUTIVES
  • TABLE 140. OPTI MEDICAL: COMPANY SNAPSHOT
  • TABLE 141. OPTI MEDICAL: OPERATING SEGMENTS
  • TABLE 142. OPTI MEDICAL: PRODUCT PORTFOLIO
  • TABLE 143. OPTI MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. SYSMEX: KEY EXECUTIVES
  • TABLE 145. SYSMEX: COMPANY SNAPSHOT
  • TABLE 146. SYSMEX: OPERATING SEGMENTS
  • TABLE 147. SYSMEX: PRODUCT PORTFOLIO
  • TABLE 148. SYSMEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. 77 ELEKTRONIKA: KEY EXECUTIVES
  • TABLE 150. 77 ELEKTRONIKA: COMPANY SNAPSHOT
  • TABLE 151. 77 ELEKTRONIKA: OPERATING SEGMENTS
  • TABLE 152. 77 ELEKTRONIKA: PRODUCT PORTFOLIO
  • TABLE 153. 77 ELEKTRONIKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. RANDOX LABORATORIES: KEY EXECUTIVES
  • TABLE 155. RANDOX LABORATORIES: COMPANY SNAPSHOT
  • TABLE 156. RANDOX LABORATORIES: OPERATING SEGMENTS
  • TABLE 157. RANDOX LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 158. RANDOX LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. BIOMéRIEUX SA: KEY EXECUTIVES
  • TABLE 160. BIOMéRIEUX SA: COMPANY SNAPSHOT
  • TABLE 161. BIOMéRIEUX SA: OPERATING SEGMENTS
  • TABLE 162. BIOMéRIEUX SA: PRODUCT PORTFOLIO
  • TABLE 163. BIOMéRIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. QUEST DIAGNOSTICS INCORPORATED: KEY EXECUTIVES
  • TABLE 165. QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT
  • TABLE 166. QUEST DIAGNOSTICS INCORPORATED: OPERATING SEGMENTS
  • TABLE 167. QUEST DIAGNOSTICS INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 168. QUEST DIAGNOSTICS INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. MERCK KGAA: KEY EXECUTIVES
  • TABLE 170. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 171. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 172. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 173. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
  • TABLE 175. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 176. LABORATORY CORPORATION OF AMERICA HOLDINGS: OPERATING SEGMENTS
  • TABLE 177. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 178. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL KIDNEY FUNCTION TEST MARKET SEGMENTATION
  • FIGURE 2. GLOBAL KIDNEY FUNCTION TEST MARKET
  • FIGURE 3. SEGMENTATION KIDNEY FUNCTION TEST MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN KIDNEY FUNCTION TEST MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALKIDNEY FUNCTION TEST MARKET
  • FIGURE 11. KIDNEY FUNCTION TEST MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. KIDNEY FUNCTION TEST MARKET FOR DIPSTICKS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. KIDNEY FUNCTION TEST MARKET FOR REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. KIDNEY FUNCTION TEST MARKET FOR DISPOSABLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. KIDNEY FUNCTION TEST MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 16. KIDNEY FUNCTION TEST MARKET FOR URINE TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. KIDNEY FUNCTION TEST MARKET FOR BLOOD TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. KIDNEY FUNCTION TEST MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 19. KIDNEY FUNCTION TEST MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. KIDNEY FUNCTION TEST MARKET FOR DIAGNOSTICS LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. KIDNEY FUNCTION TEST MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: KIDNEY FUNCTION TEST MARKET
  • FIGURE 28. TOP PLAYER POSITIONING, 2024
  • FIGURE 29. BECKMAN COULTER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. BECKMAN COULTER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. BECKMAN COULTER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. SIEMENS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. SIEMENS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. SIEMENS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. NOVA BIOMEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. NOVA BIOMEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ROCHE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ROCHE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ROCHE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. ABBOTT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. ABBOTT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. ABBOTT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. URIT MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. URIT MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. URIT MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. ARKRAY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. ARKRAY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. ARKRAY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. OPTI MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. OPTI MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. OPTI MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. SYSMEX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. SYSMEX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. SYSMEX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. 77 ELEKTRONIKA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. 77 ELEKTRONIKA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. 77 ELEKTRONIKA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. RANDOX LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. RANDOX LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. RANDOX LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. BIOMéRIEUX SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. BIOMéRIEUX SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. BIOMéRIEUX SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 65. QUEST DIAGNOSTICS INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 66. QUEST DIAGNOSTICS INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 67. QUEST DIAGNOSTICS INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 68. MERCK KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 69. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 70. MERCK KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 71. LABORATORY CORPORATION OF AMERICA HOLDINGS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 72. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 73. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Kidney Function Test Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved